Literature DB >> 9044279

Membrane translocation of diphtheria toxin fragment A exploits early to late endosome trafficking machinery.

E Lemichez1, M Bomsel, G Devilliers, J vanderSpek, J R Murphy, E V Lukianov, S Olsnes, P Boquet.   

Abstract

After reaching early endosomes by receptor-mediated endocytosis, diphtheria toxin (DT) molecules have two possible fates. A large pool enters the degradative pathway whereas a few molecules become cytotoxic by translocating their catalytic fragment A (DTA) into the cytosol. Impairment of DT degradation by microtubule depolymerization does not block DT cytotoxicity. Therefore, DTA membrane translocation into the cytosol occurs from an endocytic compartment located upstream of late endosomes. Comparisons between early endosomes and endocytic carrier vesicles in a cell-free translocation assay have demonstrated that early endosomes are the earliest endocytic compartment from which DTA translocates. DTA translocation is ATP-dependent, requires early endosomal acidification, and is increased by the addition of cytosol. Cytosol-dependent DTA translocation is GTP gamma S-insensitive but is blocked by anti-beta COP antibodies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9044279     DOI: 10.1111/j.1365-2958.1997.tb02669.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  41 in total

1.  The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step.

Authors:  S Contamin; A Galmiche; A Doye; G Flatau; A Benmerah; P Boquet
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses.

Authors:  Agnès Vendeville; Fabienne Rayne; Anne Bonhoure; Nadir Bettache; Philippe Montcourrier; Bruno Beaumelle
Journal:  Mol Biol Cell       Date:  2004-03-12       Impact factor: 4.138

Review 3.  Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors.

Authors:  Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

Review 4.  Trojan horse or proton force: finding the right partner(s) for toxin translocation.

Authors:  C Trujillo; R Ratts; A Tamayo; R Harrison; J R Murphy
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

5.  A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol.

Authors:  Ryan Ratts; Carolina Trujillo; Ajit Bharti; Johanna vanderSpek; Robert Harrison; John R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

Review 6.  Immunotoxins for targeted cancer therapy.

Authors:  Robert J Kreitman
Journal:  AAPS J       Date:  2006-08-18       Impact factor: 4.009

7.  Oxidized ATP protection against anthrax lethal toxin.

Authors:  Mahtab Moayeri; Katherine E Wickliffe; Jason F Wiggins; Stephen H Leppla
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

8.  Identification and characterization of small molecules that inhibit intracellular toxin transport.

Authors:  Jose B Saenz; Teresa A Doggett; David B Haslam
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

9.  COPI coatomer complex proteins facilitate the translocation of anthrax lethal factor across vesicular membranes in vitro.

Authors:  Alfred G Tamayo; Ajit Bharti; Carolina Trujillo; Robert Harrison; John R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-20       Impact factor: 11.205

10.  Endosome fusion induced by diphtheria toxin translocation domain.

Authors:  Antonella Antignani; Richard J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.